These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(State or other jurisdiction of
incorporation or organization)
|
(IRS employer identification no.)
|
|
Title of each class
|
Trading symbol
|
Name of exchange on which registered
|
|
|
|
|
|
|
☒
|
Accelerated filer
|
☐
|
|
Non-accelerated filer
|
☐
|
Smaller reporting company
|
|
|
Emerging growth company
|
|
|
Item 1C. Cybersecurity
|
26 |
|
Consolidated Financial Statements
|
|
| • |
MOSFETs:
Infineon, ON Semiconductor, Renesas, STMicroelectronics, Toshiba.
|
| • |
Diodes:
Diodes Inc., Nexperia, ON Semiconductor, Rohm, STMicroelectronics.
|
| • |
Optoelectronic Components:
Broadcom, ON Semiconductor, Renesas, Toshiba.
|
| • |
Resistors:
Bourns,
KOA, Murata, Panasonic, Rohm, TDK-EPCOS, Yageo.
|
| • |
Inductors:
Bourns,
Cyntec, Murata, Panasonic, Taiyo Yuden, TDK-EPCOS, Yageo.
|
| • |
Capacitors:
Kyocera, Murata, Nichicon, Panasonic, Taiyo Yuden, TDK-EPCOS, Yageo.
|
|
United States
|
2,200
|
|||
|
People’s Republic of China
|
6,900
|
|||
|
Germany
|
2,300
|
|||
|
Israel
|
2,000
|
|||
|
Taiwan
|
1,900
|
|||
|
Czech Republic
|
1,200
|
|||
|
India
|
1,100
|
|||
|
Other Europe
|
2,000
|
|||
|
Other Americas
|
1,300
|
|||
|
Other Asia
|
1,800
|
|||
|
Total
|
22,700
|
| • |
Corporate Governance Principles
|
| • |
Code of Business Conduct and Ethics
|
| • |
Code of Ethics for Financial Officers
|
| • |
Audit Committee Charter
|
| • |
Nominating and Corporate Governance Committee Charter
|
| • |
Compensation Committee Charter
|
| • |
Amended and Restated Executive Stock Ownership Guidelines
|
| • |
Director Stock Ownership Guidelines
|
| • |
Clawback Policy
|
| • |
Hedging-Pledging Policy
|
| • |
Nominating and Corporate Governance Committee Policy Regarding Qualifications of Directors
|
| • |
Related Party Transactions Policy
|
|
•
|
design and construction delays and cost overruns;
|
| • | issues installing and qualifying new equipment and ramping production; |
| • | poor production process yields and reduced quality control; and |
| • | insufficient personnel with requisite expertise and experience to operate the facilities. |
|
•
|
Adverse impact on our customers and supply channels;
|
|
•
|
Decrease in sales, product demand and pricing and unfavorable economic and market conditions;
|
|
•
|
Increased costs, including higher shipping costs due to reduced shipping capacity;
|
|
•
|
Restrictions on our manufacturing, support operations or workforce, or similar limitations for our customers, vendors, and suppliers, that could limit our
ability to meet customer demand;
|
|
•
|
Potential increased credit risk if customers, distributors, and resellers are unable to pay us, or must delay paying their obligations to us;
|
|
•
|
Restrictions or disruptions of transportation, such as reduced availability of air transport, port closures, and increased border controls or closures could
result in delays;
|
|
•
|
Impact on our workforce/employees due to the spread of the virus and any shelter-in-place orders; and
|
|
•
|
Cybersecurity risks as a result of extended periods of remote work arrangements.
|
|
•
|
the provision that our Class B common stock is generally entitled to ten votes per share, while our common stock is entitled to one vote per share, enabling the
holders of our Class B common stock to effectively control the outcome of substantially all matters submitted to a vote of our stockholders, including the election of directors and change of control transactions;
|
|
•
|
the provision establishing a classified board of directors with three-year staggered terms and the provision that a director may be removed only for cause, each
of which could delay the ability of stockholders to change the membership of a majority of our board of directors;
|
|
•
|
the ability of our board of directors to issue shares of preferred stock and to determine the price and other terms of those shares, including preferences and
voting rights, without stockholder approval, which could be used to significantly dilute the ownership of a hostile acquirer;
|
|
•
|
the right of our board of directors to elect a director to fill a vacancy created by the expansion of our board of directors or the resignation, death or removal
of a director, which prevents stockholders from being able to fill vacancies on our board of directors;
|
|
•
|
the requirement that a special meeting of stockholders may be called only by the directors or by any officer instructed by the directors to call the meeting,
which could delay the ability of our stockholders to force consideration of a proposal or to take action, including the removal of directors; and
|
|
•
|
the ability of our board of directors, by majority vote, to amend the bylaws, which may allow our board of directors to take additional actions to prevent an
unsolicited takeover and inhibit the ability of an acquirer to amend the bylaws to facilitate an unsolicited takeover attempt.
|
| • |
overall economic and business conditions;
|
| • |
competitive factors in the industries in which we conduct our business;
|
| • |
changes in governmental regulation;
|
| • |
changes in tax requirements, including tax rate changes, new tax laws, and revised tax law interpretations;
|
| • |
changes in GAAP or interpretations of GAAP by governmental agencies and self-regulatory groups;
|
| • |
interest rate fluctuations, foreign currency rate fluctuations, and other capital market conditions; and
|
| • |
economic and political conditions in international markets, including governmental changes and restrictions on the ability to transfer capital across borders.
|
|
Owned Locations
|
Business Segment
|
Approx. Available Space
(Square Feet)
|
|
|
United States
|
|||
|
Columbus, NE
|
Resistors
|
201,000
|
|
|
Bennington, VT
|
Capacitors
|
64,000
|
|
|
Yankton, SD
|
Inductors
|
60,000
|
|
|
Warwick, RI
|
Resistors
|
56,000
|
|
|
Niagara Falls, NY
|
Resistors
|
34,000
|
|
|
Marshall, MN
|
Inductors
|
22,000
|
|
|
Non-U.S.
|
|||
|
Vocklabruck, Austria
|
Diodes
|
100,000
|
|
|
People's Republic of China
|
|||
|
Tianjin
|
Diodes
|
397,000
|
|
|
Shanghai
|
Diodes
|
195,000
|
|
|
Xi'an
|
Diodes
|
133,000
|
|
|
Czech Republic
|
|||
|
Blatna
|
Resistors and Capacitors
|
276,000
|
|
|
Dolni Rychnov
|
Resistors and Capacitors
|
183,000
|
|
|
Prachatice
|
Capacitors
|
92,000
|
|
|
Volary
|
Resistors
|
35,000
|
|
|
France
|
|||
|
Nice
|
Resistors
|
221,000
|
|
|
Chateau Gontier
|
Resistors
|
82,000
|
|
|
Hyeres
|
Resistors
|
59,000
|
|
|
Germany
|
|||
|
Selb
|
Resistors and Capacitors
|
472,000
|
|
|
Heide
|
Resistors
|
264,000
|
|
| Erndtebrueck |
Capacitors
|
94,000
|
|
|
Landshut
|
Capacitors
|
75,000
|
|
|
Fichtelberg
|
Resistors
|
36,000
|
|
|
Budapest, Hungary
|
Diodes
|
101,000
|
|
|
Loni, India
|
Resistors and Capacitors
|
405,000
|
|
|
Israel
|
|||
|
Dimona
|
Resistors and Capacitors
|
404,000
|
|
|
Migdal Ha'Emek
|
Capacitors
|
288,000
|
|
|
Be'er Sheva
|
Resistors, Inductors and Capacitors
|
276,000
|
|
|
Turin, Italy
|
Diodes
|
102,000
|
|
|
Miharu, Japan
|
Capacitors
|
165,000
|
|
|
Melaka, Malaysia
|
Optoelectronic Components
|
156,000
|
|
|
Juarez, Mexico
|
Resistors
|
75,000
|
|
|
Famalicao, Portugal
|
Capacitors
|
222,000
|
|
|
Republic of China (Taiwan)
|
|||
|
Taipei
|
Diodes
|
366,000
|
|
|
Kaohsiung
|
MOSFETs
|
105,000
|
|
|
Newport, South Wales, United Kingdom
|
MOSFETs
|
439,000
|
|
Leased Locations
|
Business Segment
|
Approx. Available Space
(Square Feet)
|
|
|
United States
|
|||
|
Columbus, NE
|
Resistors
|
87,000
|
|
| Attleboro, MA | Resistors | 40,000 | |
|
Carson City, NV
|
Resistors
|
40,000
|
|
|
Ontario, CA
|
Resistors
|
38,000
|
|
|
Dover, NH
|
Inductors
|
35,000
|
|
| East Windsor, CT | Resistors | 30,000 | |
|
Hollis, NH
|
Resistors
|
25,000
|
|
|
Fremont, CA
|
Resistors
|
18,000
|
|
|
Glendale, WI
|
Resistors
|
14,000 | |
|
Hudson, MA
|
Resistors
|
13,000
|
|
|
Montevideo, MN
|
Inductors
|
11,000
|
|
|
Duluth, MN
|
Inductors
|
10,000
|
|
|
Non-U.S.
|
|||
|
Klagenfurt, Austria
|
Capacitors
|
150,000
|
|
|
People’s Republic of China
|
|||
|
Danshui
|
Capacitors, Inductors, and Resistors
|
446,000
|
|
|
Shanghai
|
MOSFETs
|
300,000
|
|
|
Shatian
|
Capacitors and Resistors
|
218,000
|
|
|
Zhuhai
|
Inductors
|
179,000
|
|
|
Long Xi
|
Resistors
|
36,000
|
|
|
Santo Domingo, Dominican Republic
|
Inductors
|
44,000
|
|
|
Germany
|
|||
|
Itzehoe
|
MOSFETs
|
217,000
|
|
|
Heilbronn
|
Diodes and Optoelectronic Components
|
163,000
|
|
|
Selb
|
Capacitors
|
47,000
|
|
|
Mumbai, India
|
Diodes
|
34,000
|
|
|
Mexico
|
|||
|
Juarez
|
Resistors
|
314,000 | |
|
Durango
|
Inductors and Resistors
|
200,000
|
|
|
Mexicali
|
Resistors
|
15,000
|
|
|
Manila, Philippines
|
Optoelectronic Components
|
149,000
|
|
|
Kaohsiung, Republic of China (Taiwan)
|
Diodes
|
130,000
|
|
Name
|
Age
|
Positions Held
|
|
|
Marc Zandman*
|
63
|
Executive Chairman of the Board, Chief Business Development Officer, and President, Vishay Israel Ltd.
|
|
|
Joel Smejkal*
|
58
|
Chief Executive Officer, President, and Director
|
|
|
David McConnell
|
58
|
Executive Vice President and Chief Financial Officer
|
|
|
Roy Shoshani
|
51
|
Executive Vice President - Chief Operating Officer - Semiconductors and Chief Technical Officer
|
|
|
Peter Henrici
|
69
|
Executive Vice President - Corporate Development
|
|
|
Michael O'Sullivan
|
50
|
Executive Vice President - Chief Administrative and Legal Officer
|
|
Common stock price range
|
Dividends declared
|
|||||||||||||||||||||||
|
2024
|
2023
|
per share
|
||||||||||||||||||||||
|
High
|
Low
|
High
|
Low
|
2024
|
2023
|
|||||||||||||||||||
|
Fourth quarter
|
$
|
20.15
|
$
|
14.95
|
$
|
25.22
|
$
|
21.15
|
$
|
0.10
|
$
|
0.10
|
||||||||||||
|
Third quarter
|
$
|
24.69
|
$
|
17.42
|
$
|
30.10
|
$
|
24.03
|
$
|
0.10
|
$
|
0.10
|
||||||||||||
|
Second quarter
|
$
|
24.19
|
$
|
20.83
|
$
|
29.66
|
$
|
20.57
|
$
|
0.10
|
$
|
0.10
|
||||||||||||
|
First quarter
|
$
|
23.92
|
$
|
20.93
|
$
|
24.48
|
$
|
20.51
|
$
|
0.10
|
$
|
0.10
|
||||||||||||
|
Period
|
Total Number of Shares Purchased
|
Average Price Paid per Share (including commission)
|
Total Number of Shares Purchased as Part of Publicly Announced Program
|
Total Dollar Amount Purchased Under the Program
|
Maximum Number of Shares that May Yet Be Purchased Under the Program
|
|||||||||||||||
|
September 29 - October 26
|
479,969
|
$
|
18.19
|
479,969
|
$
|
8,728,358
|
700,084
|
|||||||||||||
|
October 27 - November 23
|
220,413
|
17.67
|
220,413
|
3,893,706
|
479,671
|
|||||||||||||||
|
November 24 - December 31
|
-
|
-
|
-
|
-
|
3,479,671
|
|||||||||||||||
|
Total
|
700,382
|
$
|
18.02
|
700,382
|
$
|
12,622,064
|
3,479,671
|
|||||||||||||
|
Base
|
Years Ending December 31,
|
||||||||||
|
Period
|
|||||||||||
|
Company Name / Index
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
|||||
|
Vishay Intertechnology, Inc.
|
100
|
99.48
|
|
106.90
|
|
107.61
|
|
121.56
|
|
87.59
|
|
|
S&P 500 Index
|
100
|
118.40
|
|
152.39
|
|
124.79
|
|
157.59
|
|
197.02
|
|
|
S&P MidCap 400 Index
|
100
|
113.66
|
|
141.80
|
|
123.28
|
|
143.54
|
|
163.54
|
|
|
S&P SmallCap 600 Index
|
100 |
111.29
|
141.13
|
118.41
|
137.42
|
149.37
|
|||||
|
Philadelphia Semiconductor Index
|
100
|
153.66
|
|
219.51
|
|
142.94
|
|
238.72
|
|
287.31
|
|
|
Years ended December 31,
|
||||||||||||
|
2024
|
2023
|
2022
|
||||||||||
|
GAAP net earnings (loss) attributable to Vishay stockholders
|
$
|
(31,150
|
)
|
$
|
323,820
|
$
|
428,810
|
|||||
|
Reconciling items affecting gross profit:
|
||||||||||||
|
Impact of COVID-19 pandemic
|
$
|
-
|
$
|
-
|
$
|
6,661
|
||||||
|
Other reconciling items affecting operating income:
|
||||||||||||
|
Impairment of goodwill
|
$
|
66,487 |
$
|
- |
$
|
- | ||||||
|
Restructuring and severance costs
|
|
40,614 |
|
- |
|
- | ||||||
|
Impact of COVID-19 pandemic
|
- | - | 546 | |||||||||
|
Reconciling items affecting other income (expense):
|
||||||||||||
|
Loss on early extinguishment of debt
|
$
|
-
|
$
|
18,874
|
$
|
-
|
||||||
|
Reconciling items affecting tax expense (benefit):
|
||||||||||||
|
Effects of changes in uncertain tax positions
|
$ | - | $ | - | $ | (5,941 | ) | |||||
|
Effects of changes in valuation allowances
|
- | - | (33,669 | ) | ||||||||
|
Effect of change in indefinite reversal assertion
|
- |
-
|
59,642
|
|||||||||
|
Tax effects of pre-tax items above
|
(10,299
|
)
|
(498
|
)
|
(1,802
|
)
|
||||||
|
Adjusted net earnings
|
$
|
65,652
|
$
|
342,196
|
$
|
454,247
|
||||||
|
Adjusted weighted average diluted shares outstanding
|
137,741
|
140,246
|
145,495
|
|||||||||
|
Adjusted earnings per diluted share
|
$
|
0.48
|
$
|
2.44
|
$
|
3.16
|
||||||
|
Years ended December 31,
|
||||||||||||
| 2024 | 2023 | 2022 | ||||||||||
|
MOSFETS
|
$ | 87,101 |
$
|
259,386
|
$ | 274,498 | ||||||
|
Diodes
|
121,162 | 175,621 | 198,105 | |||||||||
|
Optoelectronic Components
|
38,252 | 62,226 | 102,787 | |||||||||
|
Resistors
|
158,958 | 238,428 | 262,072 | |||||||||
|
Inductors
|
107,080 | 112,414 | 104,349 | |||||||||
|
Capacitors
|
113,739 | 126,418 | 123,839 | |||||||||
|
Unallocated gross profit (loss)
|
- | - | (6,661 | ) | ||||||||
|
Gross profit
|
$ | 626,292 |
$
|
974,493
|
$ | 1,058,989 | ||||||
|
Years ended December 31,
|
||||||||||||
|
2024
|
2023
|
2022
|
||||||||||
|
Net cash provided by continuing operating activities
|
$
|
173,702
|
$
|
365,703
|
$
|
484,288
|
||||||
|
Proceeds from sale of property and equipment
|
3,015
|
1,156
|
1,198
|
|||||||||
|
Less: Capital expenditures
|
(320,079
|
)
|
(329,410
|
)
|
(325,308
|
)
|
||||||
|
Free cash
|
$
|
(143,362
|
)
|
$
|
37,449
|
$
|
160,178
|
|||||
|
Years ended
|
||||||||
| December 31, 2024 | December 31, 2023 | |||||||
|
Dividends paid to stockholders
|
$ | 54,672 | $ | 55,626 | ||||
|
Stock repurchases
|
50,406 | 78,684 | ||||||
|
Total
|
$ | 105,078 | $ | 134,310 | ||||
|
4th Quarter
2023
|
1st Quarter
2024
|
2nd Quarter
2024
|
3rd Quarter
2024
|
4th Quarter
2024
|
||||||||||||||||
|
Net revenues
|
$
|
785,236
|
$
|
746,279
|
$
|
741,239
|
$
|
735,353
|
$
|
714,716
|
||||||||||
|
Gross profit margin
|
25.6
|
%
|
22.8
|
%
|
22.0
|
%
|
20.5
|
%
|
19.9
|
%
|
||||||||||
|
Operating margin
(1)
|
9.9
|
%
|
5.7
|
%
|
5.1
|
%
|
(2.5
|
)%
|
(7.9
|
)%
|
||||||||||
|
End-of-period backlog
|
$
|
1,381,800
|
$
|
1,253,400
|
$
|
1,145,400
|
$
|
1,075,800
|
$
|
1,051,500
|
||||||||||
|
Book-to-bill ratio
|
0.75
|
0.82
|
0.86
|
0.88
|
1.01
|
|||||||||||||||
|
Inventory turnover
|
3.6
|
3.5
|
3.4
|
3.4
|
3.3
|
|||||||||||||||
|
Change in ASP vs. prior quarter
|
(0.7
|
)%
|
(2.5
|
)%
|
(0.7
|
)%
|
(1.0
|
)%
|
(0.6
|
)%
|
||||||||||
|
|
4th Quarter
2023
|
1st Quarter
2024
|
2nd Quarter
2024
|
3rd Quarter
2024
|
4th Quarter
2024
|
|||||||||||||||
|
MOSFETs
|
||||||||||||||||||||
|
Net revenues
|
$
|
168,158
|
$
|
153,173
|
$
|
155,053
|
$
|
147,134
|
$
|
146,619
|
|
|||||||||
|
Book-to-bill ratio
|
0.62
|
0.68
|
0.79
|
0.84
|
0.98
|
|||||||||||||||
|
Gross profit margin
|
27.3
|
%
|
16.6
|
%
|
13.9
|
%
|
11.7
|
%
|
15.6
|
%
|
||||||||||
|
Segment operating margin
|
16.8
|
%
|
5.3
|
%
|
1.2
|
%
|
(2.9
|
)%
|
0.8
|
%
|
||||||||||
|
Diodes
|
||||||||||||||||||||
|
Net revenues
|
$
|
163,324
|
$
|
149,130
|
$
|
146,265
|
$
|
145,183
|
$
|
141,397
|
|
|||||||||
|
Book-to-bill ratio
|
0.61
|
0.72
|
0.85
|
0.74
|
1.00
|
|||||||||||||||
|
Gross profit margin
|
24.1
|
%
|
21.7
|
%
|
21.2
|
%
|
20.1
|
%
|
20.2
|
%
|
||||||||||
|
Segment operating margin
|
20.9
|
%
|
17.4
|
%
|
16.7
|
%
|
15.7
|
%
|
16.1
|
%
|
||||||||||
|
Optoelectronic Components
|
||||||||||||||||||||
|
Net revenues
|
$
|
53,853
|
$
|
49,199
|
$
|
53,010
|
$
|
63,227
|
$
|
46,932
|
|
|||||||||
|
Book-to-bill ratio
|
0.59
|
0.89
|
0.82
|
0.77
|
1.00
|
|||||||||||||||
|
Gross profit margin
|
12.1
|
%
|
14.2
|
%
|
26.8
|
%
|
18.3
|
%
|
11.7
|
%
|
||||||||||
|
Segment operating margin
|
3.4
|
%
|
3.0
|
%
|
16.4
|
%
|
9.7
|
%
|
1.1
|
%
|
||||||||||
|
Resistors
|
||||||||||||||||||||
|
Net revenues
|
$
|
198,022
|
$
|
188,196
|
$
|
179,498
|
$
|
180,889
|
$
|
177,031
|
|
|||||||||
|
Book-to-bill ratio
|
0.82
|
0.79
|
0.87
|
0.95
|
0.91
|
|||||||||||||||
|
Gross profit margin
|
25.6
|
%
|
24.7
|
%
|
22.9
|
%
|
22.5
|
%
|
17.3
|
%
|
||||||||||
|
Segment operating margin
|
22.0
|
%
|
20.3
|
%
|
18.3
|
%
|
17.9
|
%
|
12.7
|
%
|
||||||||||
|
Inductors
|
||||||||||||||||||||
|
Net revenues
|
$
|
87,868
|
$
|
88,651
|
$
|
94,061
|
$
|
90,253
|
$
|
83,390
|
|
|||||||||
|
Book-to-bill ratio
|
0.91
|
0.96
|
0.97
|
0.83
|
1.01
|
|||||||||||||||
|
Gross profit margin
|
33.4
|
%
|
30.2
|
%
|
30.1
|
%
|
30.3
|
%
|
29.6
|
%
|
||||||||||
|
Segment operating margin
|
29.6
|
%
|
26.1
|
%
|
26.1
|
%
|
26.2
|
%
|
25.0
|
%
|
||||||||||
|
Capacitors
|
||||||||||||||||||||
|
Net revenues
|
$
|
114,011
|
$
|
117,930
|
$
|
113,352
|
$
|
108,667
|
$
|
119,347
|
|
|||||||||
|
Book-to-bill ratio
|
0.95
|
1.03
|
0.87
|
1.10
|
1.21
|
|||||||||||||||
|
Gross profit margin
|
25.3
|
%
|
27.4
|
%
|
23.5
|
%
|
22.9
|
%
|
25.1
|
%
|
||||||||||
|
Segment operating margin
|
20.4
|
%
|
22.5
|
%
|
18.5
|
%
|
17.4
|
%
|
20.0
|
%
|
||||||||||
|
Benefit
obligation
|
Plan assets
|
Funded
position
|
Informally
funded assets
|
Net position
|
Unrecognized
actuarial
items
|
|||||||||||||||||||
|
U.S. non-qualified pension plans
|
$
|
28,638
|
$
|
-
|
$
|
(28,638
|
)
|
$
|
20,907
|
$
|
(7,731
|
)
|
$
|
11
|
||||||||||
|
German pension plans
|
120,528
|
-
|
(120,528
|
)
|
4,043
|
(116,485
|
)
|
13,616
|
||||||||||||||||
|
Taiwanese pension plans
|
37,085
|
35,593
|
(1,492
|
)
|
-
|
(1,492
|
)
|
783
|
||||||||||||||||
|
Other pension plans
|
38,078
|
28,875
|
(9,203
|
)
|
-
|
(9,203
|
)
|
4,462
|
|
|||||||||||||||
|
OPEB plans
|
11,024
|
-
|
(11,024
|
)
|
-
|
(11,024
|
)
|
(171
|
)
|
|||||||||||||||
|
Other retirement obligations
|
10,518
|
-
|
(10,518
|
)
|
-
|
(10,518
|
)
|
-
|
||||||||||||||||
|
$
|
245,871
|
$
|
64,468
|
$
|
(181,403
|
)
|
$
|
24,950
|
$
|
(156,453
|
)
|
$
|
18,701
|
|||||||||||
|
Years ended December 31,
|
||||||||||||
|
2024
|
2023
|
2022
|
||||||||||
|
Costs of products sold
|
78.7
|
%
|
71.4
|
%
|
69.7
|
%
|
||||||
|
Gross profit
|
21.3
|
%
|
28.6
|
%
|
30.3
|
%
|
||||||
|
Selling, general, and administrative expenses
|
17.5
|
%
|
14.4
|
%
|
12.7
|
%
|
||||||
|
Operating income
|
0.2
|
%
|
14.3
|
%
|
17.6
|
%
|
||||||
|
Income (loss) before taxes and noncontrolling interest
|
(0.1
|
)%
|
13.7
|
%
|
17.0
|
%
|
||||||
|
Net earnings (loss) attributable to Vishay stockholders
|
(1.1
|
)%
|
9.5
|
%
|
12.3
|
%
|
||||||
|
________
|
||||||||||||
|
Effective tax rate
|
(1,145.5
|
)%
|
30.4
|
%
|
27.5
|
%
|
||||||
|
2024
|
2023
|
2022
|
||||||||||
|
Net revenues
|
$
|
2,937,587
|
$
|
3,402,045
|
$
|
3,497,401
|
||||||
|
Change versus prior year
|
$
|
(464,458
|
)
|
$
|
(95,356)
|
|||||||
|
Percentage change versus prior year
|
(13.7
|
)%
|
(2.7
|
)%
|
||||||||
|
2024 vs. 2023
|
2023 vs. 2022
|
|||||||
|
Change attributable to:
|
||||||||
|
Decrease in volume
|
(10.9
|
)%
|
(5.2
|
)%
|
||||
|
Change in average selling prices
|
(4.2
|
)%
|
1.7
|
%
|
||||
|
Foreign currency effects
|
0.0
|
%
|
0.7
|
%
|
||||
|
Acquisitions
|
1.0
|
%
|
0.2
|
%
|
||||
|
Other
|
0.4
|
%
|
(0.1
|
)%
|
||||
|
Net change
|
(13.7
|
)%
|
(2.7
|
)%
|
||||
|
Years ended December 31,
|
||||||||||||
|
2024
|
2023
|
2022
|
||||||||||
|
Net revenues
|
$
|
601,979
|
$
|
778,754
|
$
|
762,260
|
||||||
|
Change versus comparable prior year period
|
$
|
(176,775
|
)
|
$
|
16,494
|
|||||||
|
Percentage change versus comparable prior year period
|
(22.7
|
)%
|
2.2
|
%
|
||||||||
|
2024 vs. 2023
|
2023 vs. 2022
|
|||||||
|
Change attributable to:
|
||||||||
|
Decrease in volume
|
(17.4
|
)%
|
(1.8
|
)%
|
||||
|
Change in average selling prices
|
(11.0
|
)%
|
2.3
|
%
|
||||
|
Foreign currency effects
|
0.0
|
%
|
0.5
|
%
|
||||
|
Acquisition
|
3.9 | % | 1.0 | % | ||||
|
Other
|
1.8
|
%
|
0.2
|
%
|
||||
|
Net change
|
(22.7
|
)%
|
2.2
|
%
|
||||
|
Years ended December 31,
|
||||||||||||
|
2024
|
2023
|
2022
|
||||||||||
|
Gross profit margin
|
14.5 | % | 33.3 | % | 36.0 | % | ||||||
|
Segment operating margin
|
1.1 | % | 25.1 | % | 30.0 | % | ||||||
|
|
Years ended December 31,
|
|||||||||||
|
2024
|
2023
|
2022
|
||||||||||
|
Net revenues
|
$
|
581,975
|
$
|
690,540
|
$
|
765,220
|
||||||
|
Change versus comparable prior year period
|
$
|
(108,565
|
)
|
$
|
(74,680
|
)
|
||||||
|
Percentage change versus comparable prior year period
|
(15.7
|
)%
|
(9.8
|
)%
|
||||||||
|
2024 vs. 2023
|
2023 vs. 2022
|
|||||||
|
Change attributable to:
|
||||||||
|
Decrease in volume
|
(13.1
|
)%
|
(11.0
|
)%
|
||||
|
Change in average selling prices
|
(3.0
|
)%
|
1.0
|
%
|
||||
|
Foreign currency effects
|
(0.1
|
)%
|
0.4
|
%
|
||||
|
Other
|
0.5
|
%
|
(0.2
|
)%
|
||||
|
Net change
|
(15.7
|
)%
|
(9.8
|
)%
|
||||
|
Years ended December 31,
|
||||||||||||
|
2024
|
2023
|
2022
|
||||||||||
|
Gross profit margin
|
20.8
|
%
|
25.4
|
%
|
25.9
|
%
|
||||||
|
Segment operating margin
|
16.5 | % | 22.2 | % | 23.1 | % | ||||||
|
|
Years ended December 31,
|
|||||||||||
| 2024 | 2023 | 2022 | ||||||||||
|
Net revenues
|
$ | 212,368 | $ | 243,146 | $ | 296,384 | ||||||
|
Change versus comparable prior year period
|
$ | (30,778 | ) | $ | (53,238 | ) | ||||||
|
Percentage change versus comparable prior year period
|
(12.7
|
)%
|
(18.0
|
)%
|
||||||||
|
|
2024 vs. 2023
|
2023 vs. 2022
|
||||||
|
Change attributable to:
|
||||||||
|
Decrease in volume
|
(10.5 | )% | (19.2 | )% | ||||
|
Change in average selling prices
|
(2.5 | )% | 0.5 | % | ||||
|
Foreign currency effects
|
0.1 | % | 0.9 | % | ||||
|
Other
|
0.2 | % | (0.2 | )% | ||||
|
Net change
|
(12.7 | )% | (18.0 | )% | ||||
|
|
Years ended December 31,
|
|||||||||||
| 2024 | 2023 | 2022 | ||||||||||
|
Gross profit margin
|
18.0 | % | 25.6 | % | 34.7 | % | ||||||
|
Segment operating margin
|
7.9 | % | 17.7 | % | 28.8 | % | ||||||
|
Years ended December 31,
|
||||||||||||
|
2024
|
2023
|
2022
|
||||||||||
|
Net revenues
|
$
|
725,614
|
$
|
843,472
|
$
|
832,806
|
||||||
|
Change versus comparable prior year period
|
$
|
(117,858
|
)
|
$
|
10,666
|
|||||||
|
Percentage change versus comparable prior year period
|
(14.0
|
)%
|
1.3
|
%
|
||||||||
|
2024 vs. 2023
|
2023 vs. 2022
|
|||||||
|
Change attributable to:
|
||||||||
|
Decrease in volume
|
(12.0
|
)%
|
(1.4
|
)%
|
||||
|
Change in average selling prices
|
(3.0
|
)%
|
1.8
|
%
|
||||
|
Foreign currency effects
|
0.0
|
%
|
1.0
|
%
|
||||
|
Acquisitions
|
0.5 | % | 0.0 | % | ||||
|
Other
|
0.5
|
%
|
(0.1
|
)%
|
||||
|
Net change
|
(14.0
|
)%
|
1.3
|
%
|
||||
|
Years ended December 31,
|
||||||||||||
|
2024
|
2023
|
2022
|
||||||||||
|
Gross profit margin
|
21.9
|
%
|
28.3
|
%
|
31.5
|
%
|
||||||
|
Segment operating margin
|
17.3 | % | 24.8 | % | 28.2 | % | ||||||
|
Years ended December 31,
|
||||||||||||
|
2024
|
2023
|
2022
|
||||||||||
|
Net revenues
|
$
|
356,355
|
$
|
347,392
|
$
|
331,086
|
||||||
|
Change versus comparable prior year period
|
$
|
8,963
|
|
$
|
16,306
|
|
||||||
|
Percentage change versus comparable prior year period
|
2.6
|
%
|
4.9
|
%
|
||||||||
|
2024 vs. 2023
|
2023 vs. 2022
|
|||||||
|
Change attributable to:
|
||||||||
|
Increase in volume
|
4.8
|
%
|
2.4
|
%
|
||||
|
Change in average selling prices
|
(2.2
|
)%
|
1.9
|
%
|
||||
|
Foreign currency effects
|
0.0
|
%
|
0.5
|
%
|
||||
|
Other
|
0.0
|
%
|
0.1
|
%
|
||||
|
Net change
|
2.6
|
%
|
4.9
|
%
|
||||
|
Years ended December 31,
|
||||||||||||
|
2024
|
2023
|
2022
|
||||||||||
|
Gross profit margin
|
30.0
|
%
|
32.4
|
%
|
31.5
|
%
|
||||||
|
Segment operating margin
|
25.9 | % | 28.7 | % | 28.2 | % | ||||||
|
Years ended December 31,
|
||||||||||||
|
2024
|
2023
|
2022
|
||||||||||
|
Net revenues
|
$
|
459,296
|
$
|
498,741
|
$
|
509,645
|
||||||
|
Change versus comparable prior year period
|
$
|
(39,445
|
)
|
$
|
(10,904)
|
|||||||
|
Percentage change versus comparable prior year period
|
(7.9
|
)%
|
(2.1
|
)%
|
||||||||
|
2024 vs. 2023
|
2023 vs. 2022
|
|||||||
|
Change attributable to:
|
||||||||
|
Decrease in volume
|
(7.2
|
)%
|
(5.1
|
)%
|
||||
|
Change in average selling prices
|
(0.5
|
)%
|
2.2
|
%
|
||||
|
Foreign currency effects
|
0.0
|
%
|
0.9
|
%
|
||||
|
Other
|
(0.2
|
)%
|
(0.1
|
)%
|
||||
|
Net change
|
(7.9
|
)%
|
(2.1
|
)%
|
||||
|
Years ended December 31,
|
||||||||||||
|
2024
|
2023
|
2022
|
||||||||||
|
Gross profit margin
|
24.8
|
%
|
25.3
|
%
|
24.3
|
%
|
||||||
|
Segment operating margin
|
19.7 | % | 21.1 | % | 20.6 | % | ||||||
|
Years ended December 31,
|
||||||||||||
|
2024
|
2023
|
2022
|
||||||||||
|
Total SG&A expenses
|
$
|
513,564
|
$
|
488,349
|
$
|
443,503
|
||||||
|
as a percentage of sales
|
17.5
|
%
|
14.4
|
%
|
12.7
|
%
|
||||||
|
Years ended December 31,
|
||||||||||||
|
2024
|
2023
|
Change
|
||||||||||
|
Foreign exchange gain (loss)
|
$
|
774
|
$
|
677
|
$
|
97
|
||||||
|
Interest income
|
25,479
|
31,353
|
(5,874
|
)
|
||||||||
|
Other components of net periodic pension expense
|
(7,899
|
)
|
(8,730
|
)
|
831
|
|||||||
|
Investment income
|
(519
|
)
|
1,347
|
(1,866
|
)
|
|||||||
|
Other
|
1,629
|
616
|
1,013
|
|||||||||
|
$
|
19,464
|
$
|
25,263
|
$
|
(5,799
|
)
|
||||||
|
Years ended December 31,
|
||||||||||||
|
2023
|
2022
|
Change
|
||||||||||
|
Foreign exchange gain
|
$
|
677
|
$
|
5,690
|
$
|
(5,013
|
)
|
|||||
|
Interest income
|
31,353
|
7,560
|
23,793
|
|||||||||
|
Other components of net periodic pension expense
|
(8,730
|
)
|
(11,090
|
)
|
2,360
|
|||||||
|
Investment income (loss)
|
1,347
|
(6,812
|
)
|
8,159
|
||||||||
|
Other
|
616
|
(200
|
)
|
816
|
||||||||
|
$
|
25,263
|
$
|
(4,852
|
)
|
$
|
30,115
|
||||||
|
4th Quarter 2023
|
1st Quarter 2024
|
2nd Quarter 2024
|
3rd Quarter 2024
|
4th Quarter 2024
|
||||||||||||||||
|
Days sales outstanding ("DSO")
(a)
|
50
|
51
|
51
|
53
|
53
|
|||||||||||||||
|
Days inventory outstanding ("DIO")
(b)
|
101
|
104
|
105
|
106
|
109
|
|||||||||||||||
|
Days payable outstanding ("DPO")
(c)
|
(31
|
)
|
(31
|
)
|
(31
|
)
|
(32
|
)
|
(34
|
)
|
||||||||||
|
Cash conversion cycle
|
120
|
124
|
125
|
127
|
128
|
|||||||||||||||
|
|
December 31,
2024
|
December 31,
2023
|
||||||
|
Credit facility
|
$
|
136,000
|
$
|
-
|
||||
|
Convertible senior notes, due 2025
|
41,911
|
95,102
|
||||||
|
Convertible senior notes, due 2030
|
750,000 | 750,000 | ||||||
|
Deferred financing costs
|
(22,892
|
)
|
(26,914
|
)
|
||||
|
Total debt
|
905,019
|
818,188
|
||||||
|
Cash and cash equivalents
|
590,286
|
972,719
|
||||||
|
Short-term investments
|
16,130
|
35,808
|
||||||
|
Net cash and short-term investments (debt)
|
$
|
(298,603
|
)
|
$
|
190,339
|
|||
|
Payments due by period
|
||||||||||||||||||||||||||||
|
Total
|
2025
|
2026
|
2027
|
2028
|
2029
|
Thereafter
|
||||||||||||||||||||||
|
Long-term debt
|
$
|
927,911
|
$
|
41,911
|
$
|
-
|
$
|
-
|
$
|
136,000
|
$
|
-
|
$
|
750,000
|
||||||||||||||
|
Interest payments on long-term debt
|
134,963
|
28,688
|
28,256
|
28,256
|
20,935
|
16,875
|
11,953
|
|||||||||||||||||||||
|
Operating leases
|
159,089
|
26,681
|
22,803
|
19,266
|
15,724
|
13,690
|
60,925
|
|||||||||||||||||||||
|
Letters of credit
|
2,062
|
-
|
-
|
-
|
2,062
|
-
|
-
|
|||||||||||||||||||||
|
Expected pension and postretirement plan funding
|
182,947
|
20,182
|
18,855
|
17,601
|
23,412
|
18,773
|
84,124
|
|||||||||||||||||||||
|
Estimated costs to complete construction in progress
|
158,900
|
121,200
|
33,200
|
4,500
|
-
|
-
|
-
|
|||||||||||||||||||||
|
Estimated costs to complete MOSFETs wafer fab
|
337,200 | 143,200 | 168,100 | 25,900 | - | - | - | |||||||||||||||||||||
|
TCJA transition tax
|
47,027
|
47,027
|
-
|
-
|
-
|
-
|
-
|
|||||||||||||||||||||
|
Uncertain tax positions
|
14,647
|
1,515
|
-
|
-
|
-
|
-
|
13,132
|
|||||||||||||||||||||
|
Purchase commitments
|
85,791
|
74,551
|
8,295
|
2,945
|
-
|
-
|
-
|
|||||||||||||||||||||
|
Other long-term liabilities
|
90,954
|
-
|
-
|
-
|
-
|
-
|
90,954
|
|||||||||||||||||||||
|
Total contractual cash obligations
|
$ | 2,141,491 |
$
|
504,955 |
$
|
279,509 |
$
|
98,468 |
$
|
198,133
|
$
|
49,338
|
$
|
1,011,088
|
||||||||||||||
| 1. |
Financial Statements
|
| 2. |
Financial Statement Schedules
|
| 3. |
Exhibits
|
|
By:
|
/s/ Joel Smejkal
|
|
|
Joel Smejkal
|
||
|
President and Chief Executive Officer
|
||
|
February 14, 2025
|
|
Signature
|
Title
|
Date
|
|
Principal Executive Officer:
|
||
|
/s/ Joel Smejkal
|
President, Chief Executive Officer,
|
February 14, 2025
|
|
Joel Smejkal
|
and Director
|
|
|
Principal Financial Officer:
|
||
|
/s/ David E. McConnell
|
Executive Vice President and
|
February 14, 2025
|
|
David E. McConnell
|
Chief Financial Officer
|
|
|
Principal Accounting Officer:
|
||
|
/s/ David L. Tomlinson
|
Senior Vice President and
|
February 14, 2025
|
|
David L. Tomlinson
|
Chief Accounting Officer
|
|
|
Board of Directors:
|
||
|
/s/ Marc Zandman
|
Executive Chairman of
|
February 14, 2025
|
|
Marc Zandman
|
the Board of Directors
|
|
|
/s/ Renee B. Booth
|
Director
|
February 14, 2025
|
|
Dr. Renee B. Booth
|
||
|
/s/ Michael J. Cody
|
Director
|
February 14, 2025
|
|
Michael J. Cody
|
||
|
/s/
Michiko Kurahashi
|
Director
|
February 14, 2025
|
|
Dr.
Michiko Kurahashi
|
||
|
/s/ Abraham Ludomirski
|
Director
|
February 14, 2025
|
|
Dr. Abraham Ludomirski
|
||
|
/s/ John Malvisi
|
Director
|
February 14, 2025 |
|
John Malvisi
|
||
|
/s/ Ziv Shoshani
|
Director
|
February 14, 2025
|
|
Ziv Shoshani
|
||
|
/s/ Timothy V. Talbert
|
Director
|
February 14, 2025
|
|
Timothy V. Talbert
|
||
|
/s/ Ruta Zandman
|
Director
|
February 14, 2025
|
|
Ruta Zandman
|
||
|
/s/ Raanan Zilberman
|
Director
|
February 14, 2025
|
|
Raanan Zilberman
|
|
Report of Independent Registered Public Accounting Firm (PCAOB ID:
42
)
|
|
|
Audited Consolidated Financial Statements
|
|
|
Sales Returns and Allowances Accruals
|
||
|
Description of the Matter
|
At December 31, 2024, the Company’s liability for sales returns and allowances was $43.4 million. As discussed in Note 1 of
the consolidated financial statements, the Company recognizes the estimated variable consideration to be received from contracts with customers as revenue and recognizes a related accrued liability for estimated future credits that will be
issued to its customers, primarily distributors, for product returns, scrap allowance, “stock, ship and debit”, and price protection programs with those customers.
Auditing management’s sales returns and allowances accruals specifically related to the scrap allowance and “stock, ship and
debit” programs was especially challenging because of the judgement used by management to determine the amount of future credits that will be issued to customers for sales that were recognized during the period. Estimating the scrap
allowance and “stock, ship and debit” accrual involves the application of models which require management to make certain assumptions including historical customer credit rates.
|
|
|
How We Addressed the Matter in Our Audit
|
We obtained an understanding, evaluated the design and tested the operating effectiveness of controls over the Company’s sales
returns and allowances review process for the scrap allowance and “stock, ship and debit” programs, including testing controls over management’s review of the reserve calculation and the underlying assumptions used to develop the estimates.
To test the estimated sales returns and allowances accruals for the scrap allowance and “stock, ship and debit” programs, we
performed audit procedures that included, among others, assessing methodologies and testing the assumptions discussed above and the completeness and accuracy of the underlying data used by the Company in its analyses. We inspected contracts
with customers in evaluating whether the assumptions used by management agreed with the terms and conditions of the contracts. In addition, we compared the assumptions used by management to actual historical credit experience. We also
assessed the historical accuracy of management’s estimates and performed sensitivity analyses of significant assumptions to evaluate the changes in the accruals that would result from changes in the assumptions.
|
|
|
Goodwill Impairment
|
||
|
Description of the Matter
|
At December 31, 2024, the Company’s goodwill balance was $179.0 million. As discussed in Note 1 and Note 19 of the consolidated
financial statements, the Company’s goodwill is tested for impairment at least annually, or whenever events or circumstances indicate that the value of goodwill may be impaired. If goodwill is determined to be impaired, an impairment loss is
measured at the amount by which the reporting unit’s carrying amount exceeds its fair value, not to exceed the carrying amount of goodwill. During the fourth quarter of 2024, the Company identified impairment indicators related to goodwill
within the MOSFETs reporting unit. The Company performed a quantitative assessment of the reporting unit to determine its fair value. Based on the Company’s evaluation, the estimated fair value of the reporting unit was determined to be less
than its carrying value. As a result, a non-cash goodwill impairment charge of $66.5 million was recognized.
Auditing the Company’s goodwill impairment assessment for the MOSFETs reporting unit was complex and highly judgmental due to
the significant judgments and estimation required by management in determining the fair value of the reporting unit, which is based on assumptions about future market or economic conditions and company-specific qualitative factors whose
outcome is uncertain and will therefore be subject to change over time. In particular, the fair value estimate of the reporting unit involves the use of significant unobservable inputs and is sensitive to changes in significant assumptions,
such as the discount rate, revenue growth rate, and earnings before interest, taxes, depreciation and amortization ("EBITDA").
|
|
|
How We Addressed the Matter in Our Audit
|
We obtained an understanding, evaluated the design and tested the operating effectiveness of controls over the Company's
goodwill impairment review and testing process over the MOSFETs reporting unit. For example, we tested controls over management’s review of the valuation model, the significant assumptions described above, and the completeness and accuracy of
the data used in the valuation.
To test the estimated fair value for the MOSFETs reporting unit, we performed audit procedures that included, among others,
assessing the methodologies used to develop the estimated fair values, testing the significant assumptions discussed above, and evaluating the completeness and accuracy of the underlying data used by the Company in its analyses. We compared
the significant assumptions used by management to historical results and current industry trends. We performed sensitivity analyses of significant assumptions to evaluate the changes in the fair value of the reporting units that would result
from changes in the assumptions. We also involved valuation specialists to assist in our evaluation of the overall methodologies and the discount rate used in the fair value estimate.
|
|
|
|
December 31,
2024
|
December 31,
2023
|
||||||
|
|
||||||||
|
Assets
|
||||||||
|
Current assets:
|
||||||||
|
Cash and cash equivalents
|
$ |
|
$
|
|
||||
|
|
||||||||
|
Short-term investments
|
|
|
||||||
|
|
||||||||
|
Accounts receivable, net of allowances for credit losses of $
|
|
|
||||||
|
|
||||||||
|
Inventories:
|
||||||||
|
Finished goods
|
|
|
||||||
|
Work in process
|
|
|
||||||
|
Raw materials
|
|
|
||||||
|
Total inventories
|
|
|
||||||
|
|
||||||||
|
Prepaid expenses and other current assets
|
|
|
||||||
|
Total current assets
|
|
|
||||||
|
|
||||||||
|
Property and equipment, at cost:
|
||||||||
|
Land
|
|
|
||||||
|
Buildings and improvements
|
|
|
||||||
|
Machinery and equipment
|
|
|
||||||
|
Construction in progress
|
|
|
||||||
|
Allowance for depreciation
|
(
|
)
|
(
|
)
|
||||
|
Property and equipment, net
|
|
|
||||||
|
|
||||||||
|
Right of use assets
|
|
|
||||||
|
Deferred income taxes
|
|
|
||||||
|
Goodwill
|
|
|
||||||
|
|
||||||||
|
Other intangible assets, net
|
|
|
||||||
|
|
||||||||
|
Other assets
|
|
|
||||||
|
Total assets
|
$
|
|
$
|
|
||||
|
December 31,
2024
|
December 31,
2023
|
|||||||
|
Liabilities and equity
|
||||||||
|
Current liabilities:
|
||||||||
|
Trade accounts payable
|
$
|
|
$
|
|
||||
|
Payroll and related expenses
|
|
|
||||||
|
Lease liabilities
|
|
|
||||||
|
Other accrued expenses
|
|
|
||||||
|
Income taxes
|
|
|
||||||
|
Total current liabilities
|
|
|
||||||
|
|
||||||||
|
Long-term debt, less current portion
|
|
|
||||||
|
U.S. transition tax payable
|
|
|
||||||
|
Deferred income taxes
|
|
|
||||||
|
Long-term lease liabilities
|
|
|
||||||
|
Other liabilities
|
|
|
||||||
|
Accrued pension and other postretirement costs
|
|
|
||||||
|
Total liabilities
|
|
|
||||||
|
|
||||||||
|
Commitments and contingencies
|
|
|
||||||
|
|
||||||||
|
Stockholders' equity:
|
||||||||
|
Preferred stock, par value $
|
|
|
||||||
|
Common stock, par value $
|
|
|
||||||
|
Class B convertible common stock, par value $
|
|
|
||||||
|
Capital in excess of par value
|
|
|
||||||
|
Retained earnings
|
|
|
||||||
|
Treasury stock (at cost):
|
(
|
) |
(
|
) | ||||
|
Accumulated other comprehensive income (loss)
|
(
|
)
|
|
|||||
|
Total Vishay stockholders' equity
|
|
|
||||||
|
Noncontrolling interests
|
|
|
||||||
|
Total equity
|
|
|
||||||
|
Total liabilities and equity
|
$
|
|
$
|
|
||||
|
Years ended December 31,
|
||||||||||||
|
2024
|
2023
|
2022
|
||||||||||
|
Net revenues
|
$
|
|
$
|
|
$
|
|
||||||
|
Costs of products sold
|
|
|
|
|||||||||
|
Gross profit
|
|
|
|
|||||||||
|
Selling, general, and administrative expenses
|
|
|
|
|||||||||
|
Restructuring and severance costs
|
|
|
|
|||||||||
|
Impairment of goodwill
|
|
|
|
|||||||||
|
Operating income
|
|
|
|
|||||||||
|
Other income (expense):
|
||||||||||||
|
Interest expense
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Other
|
|
|
(
|
)
|
||||||||
|
Loss on early extinguishment of debt
|
|
(
|
)
|
|
||||||||
|
Total other income (expense)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Income (loss) before taxes
|
(
|
)
|
|
|
||||||||
|
Income tax expense
|
|
|
|
|||||||||
|
Net earnings (loss)
|
(
|
)
|
|
|
||||||||
|
Less: net earnings attributable to noncontrolling interests
|
|
|
|
|||||||||
|
Net earnings (loss) attributable to Vishay stockholders
|
$
|
(
|
)
|
$
|
|
$
|
|
|||||
|
Basic earnings (loss) per share attributable to Vishay stockholders:
|
$
|
(
|
)
|
$
|
|
$
|
|
|||||
|
Diluted earnings (loss) per share attributable to Vishay stockholders:
|
$
|
(
|
)
|
$
|
|
$
|
|
|||||
|
Weighted average shares outstanding - basic
|
|
|
|
|||||||||
|
Weighted average shares outstanding - diluted
|
|
|
|
|||||||||
|
Cash dividends per share
|
$
|
|
$
|
|
$
|
|
||||||
|
Years ended December 31,
|
||||||||||||
|
2024
|
2023
|
2022
|
||||||||||
|
Net earnings (loss)
|
$
|
(
|
)
|
$
|
|
$
|
|
|||||
|
Other comprehensive income (loss), net of tax
|
||||||||||||
|
Pension and other post-retirement actuarial items
|
|
(
|
)
|
|
||||||||
|
Foreign currency translation adjustment
|
(
|
)
|
|
(
|
)
|
|||||||
|
Other comprehensive income (loss)
|
(
|
)
|
|
|
||||||||
|
Comprehensive income (loss)
|
(
|
)
|
|
|
||||||||
|
Less: comprehensive income attributable to noncontrolling interests
|
|
|
|
|||||||||
|
Comprehensive income (loss) attributable to Vishay stockholders
|
$
|
(
|
)
|
$
|
|
$
|
|
|||||
|
Years ended December 31,
|
||||||||||||
|
2024
|
2023
|
2022
|
||||||||||
|
Operating activities
|
||||||||||||
|
Net earnings (loss)
|
$
|
(
|
)
|
$
|
|
$
|
|
|||||
|
Adjustments to reconcile net earnings (loss) to net cash provided by operating activities:
|
||||||||||||
|
Depreciation and amortization
|
|
|
|
|||||||||
|
Gain on disposal of property and equipment
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Inventory write-offs for obsolescence
|
|
|
|
|||||||||
|
Impairment of goodwill
|
|
|
|
|||||||||
|
Pensions and other postretirement benefits, net of contributions
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Stock compensation expense
|
|
|
|
|||||||||
| Loss on early extinguishment of debt |
|
|
|
|||||||||
|
Deferred income taxes
|
(
|
)
|
|
|
||||||||
|
Other operating activities
|
|
|
|
|||||||||
|
Change in U.S. transition tax liability
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Change in repatriation tax liability
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Net change in operating assets and liabilities, net of effects of businesses acquired
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Net cash provided by operating activities
|
|
|
|
|||||||||
|
Investing activities
|
||||||||||||
|
Capital expenditures
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Proceeds from sale of property and equipment
|
|
|
|
|||||||||
|
Purchase of and deposits for businesses, net of cash acquired
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Purchase of short-term investments
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Maturity of short-term investments
|
|
|
|
|||||||||
|
Other investing activities
|
|
(
|
)
|
(
|
)
|
|||||||
|
Net cash used in investing activities
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Financing activities
|
||||||||||||
|
Proceeds from long-term borrowings
|
|
|
|
|||||||||
|
Repurchase of convertible senior notes due 2025
|
(
|
) |
(
|
) |
|
|||||||
|
Net proceeds (payments) on revolving credit facility
|
|
(
|
) |
|
||||||||
|
Debt issuance and amendment costs
|
(
|
) |
(
|
) |
|
|||||||
|
Cash paid for capped call
|
|
(
|
) |
|
||||||||
|
Dividends paid to common stockholders
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Dividends paid to Class B common stockholders
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Repurchase of common stock held in treasury
|
(
|
) |
(
|
) |
(
|
) | ||||||
|
Distributions to noncontrolling interests
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Acquisition of noncontrolling interests
|
(
|
) |
|
|
||||||||
|
Cash withholding taxes paid when shares withheld for vested equity awards
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Net cash provided by (used in) financing activities
|
(
|
)
|
|
(
|
)
|
|||||||
|
Effect of exchange rate changes on cash and cash equivalents
|
(
|
)
|
|
(
|
)
|
|||||||
|
Net increase (decrease) in cash and cash equivalents
|
(
|
) |
|
(
|
)
|
|||||||
|
Cash and cash equivalents at beginning of year
|
|
|
|
|||||||||
|
Cash and cash equivalents at end of year
|
$
|
|
$
|
|
$
|
|
||||||
|
Common
Stock
|
Class B
Convertible
Common
Stock
|
Capital in
Excess of Par
Value
|
Retained
Earnings
(Accumulated
Deficit)
|
Treasury Stock
|
Accumulated
Other
Comprehensive
Income (Loss)
|
Total Vishay
Stockholders'
Equity
|
Noncontrolling
Interests
|
Total Equity
|
||||||||||||||||||||||||||||
|
Balance at December 31, 2021
|
$
|
|
$
|
|
$
|
|
$
|
|
$ |
|
$
|
(
|
)
|
$
|
|
$
|
|
$
|
|
|||||||||||||||||
|
Net earnings
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||
|
Other comprehensive income (loss)
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||
|
Distributions to noncontrolling interests
|
|
|
|
|
|
|
|
(
|
) |
(
|
) | |||||||||||||||||||||||||
|
Issuance of stock and related tax withholdings for vested restricted stock units (
|
|
|
(
|
)
|
|
|
|
(
|
)
|
|
(
|
)
|
||||||||||||||||||||||||
|
Dividends declared ($
|
|
|
|
(
|
)
|
|
|
(
|
)
|
|
(
|
)
|
||||||||||||||||||||||||
|
Stock compensation expense
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||
|
Repurchase of common stock held in treasury (
|
|
|
|
|
(
|
) |
|
(
|
) |
|
(
|
) | ||||||||||||||||||||||||
|
Balance at December 31,
2022
|
$
|
|
$
|
|
$
|
|
$
|
|
$ |
(
|
) |
$
|
(
|
)
|
$
|
|
$
|
|
$
|
|
||||||||||||||||
|
Net earnings
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||
|
Other comprehensive income
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||
|
Distributions to noncontrolling interests
|
|
|
|
|
|
|
|
(
|
)
|
(
|
)
|
|||||||||||||||||||||||||
|
Issuance of stock and related tax withholdings for vested restricted stock units (
|
|
|
(
|
)
|
|
|
|
(
|
)
|
|
(
|
)
|
||||||||||||||||||||||||
|
Dividends declared ($
|
|
|
|
(
|
)
|
|
|
(
|
)
|
|
(
|
)
|
||||||||||||||||||||||||
|
Stock compensation expense
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||
|
Repurchase of common stock held in treasury (
|
|
|
|
|
(
|
) |
|
(
|
) |
|
(
|
) | ||||||||||||||||||||||||
|
Capped call transactions, net of tax
|
|
|
(
|
) |
|
|
|
(
|
) |
|
(
|
) | ||||||||||||||||||||||||
|
Balance at December 31,
2023
|
$
|
|
$
|
|
$
|
|
$
|
|
$ |
(
|
) |
$
|
|
$
|
|
$
|
|
$
|
|
|||||||||||||||||
|
Net earnings (loss)
|
|
|
|
(
|
)
|
|
|
(
|
)
|
|
(
|
)
|
||||||||||||||||||||||||
|
Other comprehensive income (loss)
|
|
|
|
|
|
(
|
)
|
(
|
)
|
|
(
|
)
|
||||||||||||||||||||||||
|
Distributions to noncontrolling interests
|
|
|
|
|
|
|
|
(
|
)
|
(
|
)
|
|||||||||||||||||||||||||
|
Acquisition of noncontrolling interests
|
|
|
(
|
) |
|
|
|
(
|
) |
(
|
) |
(
|
) | |||||||||||||||||||||||
|
Issuance of stock and related tax withholdings for vested restricted stock units (
|
|
|
(
|
)
|
|
|
|
(
|
)
|
|
(
|
)
|
||||||||||||||||||||||||
|
Dividends declared ($
|
|
|
|
(
|
)
|
|
|
(
|
)
|
|
(
|
)
|
||||||||||||||||||||||||
|
Stock compensation expense
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||
|
Repurchase of common stock held in treasury (
|
|
|
|
|
(
|
) |
|
(
|
) |
|
(
|
) | ||||||||||||||||||||||||
|
Balance at December 31,
2024
|
$ |
|
$
|
|
$ |
|
$ |
|
$ |
(
|
) |
$
|
(
|
)
|
$
|
|
$
|
|
$
|
|
||||||||||||||||
|
Net working deficit (excluding cash and cash equivalents)
|
$ |
(
|
)
|
|
|
Property and equipment
|
|
|||
|
Customer relationships
|
|
|||
|
Other, net
|
|
|||
|
Deferred taxes, net
|
(
|
)
|
||
|
Total identified assets and liabilities
|
|
|||
|
|
||||
|
Purchase price, net of cash acquired
|
|
|||
|
|
||||
|
Goodwill
|
$ |
|
|
●
|
Selling, general, and administrative functions will be streamlined through the fourth fiscal quarter of 2025.
|
| ● | The closure of three manufacturing facilities. A Diodes segment back-end facility in Shanghai, China is expected to be closed by the end of 2026 with production transfers completed in phases beginning in the fourth quarter of 2025. In addition, two small facilities in the Resistors segment in Fichtelberg, Germany, and in Milwaukee, Wisconsin, are expected to be closed in 2026. |
| ● |
Various changes in manufacturing operations and production transfers.
|
|
Expense recorded in 2024
|
$
|
|
||
|
Cash paid
|
(
|
)
|
||
|
Foreign currency translation
|
(
|
)
|
||
|
Balance at December 31, 2024
|
$
|
|
|
|
December 31,
2024
|
December 31,
2023
|
||||||
|
Right of use assets
|
||||||||
|
Operating Leases
|
||||||||
|
Buildings and improvements
|
$
|
|
$
|
|
||||
|
Machinery and equipment
|
|
|
||||||
|
Total
|
$
|
|
$
|
|
||||
|
Current lease liabilities
|
||||||||
|
Operating Leases
|
||||||||
|
Buildings and improvements
|
$
|
|
$
|
|
||||
|
Machinery and equipment
|
|
|
||||||
|
Total
|
$
|
|
$
|
|
||||
|
Long-term lease liabilities
|
||||||||
|
Operating Leases
|
||||||||
|
Buildings and improvements
|
$
|
|
$
|
|
||||
|
Machinery and equipment
|
|
|
||||||
|
Total
|
$
|
|
$
|
|
||||
|
Total lease liabilities
|
$
|
|
$
|
|
||||
|
|
Years ended December 31,
|
|||||||||||
|
|
2024
|
2023
|
2022
|
|||||||||
|
Lease expense
|
||||||||||||
|
Operating lease expense
|
$
|
|
$
|
|
$
|
|
||||||
|
Short-term lease expense
|
|
|
|
|||||||||
|
Variable lease expense
|
|
|
|
|||||||||
|
Total lease expense
|
$
|
|
$
|
|
$
|
|
||||||
|
2025
|
$
|
|
||
|
2026
|
|
|||
|
2027
|
|
|||
|
2028
|
|
|||
|
2029
|
|
|||
|
Thereafter
|
|
|
Years ended December 31,
|
||||||||||||
|
|
2024
|
2023
|
2022
|
|||||||||
|
|
||||||||||||
|
Domestic
|
$
|
(
|
)
|
$
|
|
$
|
|
|||||
|
Foreign
|
|
|
|
|||||||||
|
|
$
|
(
|
)
|
$
|
|
$
|
|
|||||
|
Years ended December 31,
|
||||||||||||
|
|
2024
|
2023
|
2022
|
|||||||||
|
|
||||||||||||
|
Current:
|
||||||||||||
|
Federal
|
$
|
|
$
|
|
$
|
|
||||||
|
State and local
|
|
|
|
|||||||||
|
Foreign
|
|
|
|
|||||||||
|
|
|
|
||||||||||
|
Deferred:
|
||||||||||||
|
Federal
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
State and local
|
(
|
)
|
(
|
)
|
|
|||||||
|
Foreign
|
(
|
)
|
(
|
)
|
|
|||||||
|
(
|
)
|
(
|
)
|
|
||||||||
|
Total income tax expense
|
$
|
|
$
|
|
$
|
|
||||||
|
December 31,
|
||||||||
|
|
2024
|
2023
|
||||||
|
Deferred tax assets:
|
||||||||
|
Pension and other retiree obligations
|
$
|
|
$
|
|
||||
|
Inventories
|
|
|
||||||
|
Net operating loss carryforwards
|
|
|
||||||
|
Tax credit carryforwards
|
|
|
||||||
|
Research and development costs
|
|
|
||||||
|
Interest
|
|
|
||||||
|
Other accruals and reserves
|
|
|
||||||
|
Total gross deferred tax assets
|
|
|
||||||
|
Less valuation allowance
|
(
|
)
|
(
|
)
|
||||
|
|
|
|||||||
|
Deferred tax liabilities:
|
||||||||
|
Property and equipment
|
(
|
)
|
(
|
)
|
||||
|
Tax deductible goodwill
|
(
|
)
|
(
|
)
|
||||
|
Intangibles other than goodwill
|
(
|
) |
(
|
) | ||||
|
Earnings not indefinitely reinvested
|
(
|
)
|
(
|
)
|
||||
|
Other - net
|
(
|
)
|
(
|
)
|
||||
|
Total gross deferred tax liabilities
|
(
|
)
|
(
|
)
|
||||
|
Net deferred tax assets
|
$
|
|
$
|
|
||||
|
Years ended December 31,
|
||||||||||||
|
|
2024
|
2023
|
2022
|
|||||||||
|
Tax at statutory rate
|
$
|
(
|
)
|
$
|
|
$
|
|
|||||
|
State income taxes, net of U.S. federal tax benefit
|
(
|
)
|
(
|
)
|
|
|||||||
|
Effect of foreign operations
|
(
|
)
|
|
|
||||||||
|
Impairment of goodwill
|
|
|
|
|||||||||
|
Tax on earnings not indefinitely reinvested
|
|
|
|
|||||||||
|
Change in valuation allowance on deferred tax assets
|
|
(
|
)
|
(
|
)
|
|||||||
|
Foreign income taxable in the U.S.
|
|
|
|
|||||||||
|
Foreign tax credit
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
U.S. Base Erosion Anti-Abuse Tax
|
|
|
|
|||||||||
|
Other
|
|
|
|
(
|
)
|
|||||||
|
Total income tax expense
|
$
|
|
$
|
|
$
|
|
||||||
|
|
Expires
|
|||||||
|
Belgium
|
$
|
|
No expiration
|
|||||
|
Israel
|
|
No expiration
|
||||||
|
Italy
|
|
No expiration
|
||||||
|
Japan
|
|
2025
-
2033
|
||||||
|
Netherlands
|
|
No expiration
|
||||||
|
The Republic of China (Taiwan)
|
|
2027
-
2028
|
||||||
|
United Kingdom
|
|
No expiration
|
||||||
|
|
||||||||
|
California
|
|
2028
-
2037
|
||||||
|
Pennsylvania
|
|
2025
-
2044
|
||||||
|
Arizona
|
|
2032 - 2044 | ||||||
|
|
Expires
|
|||||||
|
U.S. Foreign Tax Credit
|
$
|
|
2028
-
2034
|
|||||
|
California Research Credit
|
|
No expiration
|
||||||
|
|
Years ended December 31,
|
|||||||||||
|
|
2024
|
2023
|
2022
|
|||||||||
|
|
||||||||||||
|
Balance at beginning of year
|
$
|
|
$
|
|
$
|
|
||||||
|
Addition based on tax positions related to the current year
|
|
|
|
|||||||||
|
Addition based on tax positions related to prior years
|
|
|
|
|||||||||
|
Currency translation adjustments
|
(
|
)
|
|
(
|
)
|
|||||||
|
Reduction for settlements
|
|
(
|
)
|
(
|
)
|
|||||||
|
Reduction for lapses of statute of limitation
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Balance at end of year
|
$
|
|
$
|
|
$
|
|
||||||
|
December 31,
2024
|
December 31,
2023
|
|||||||
|
Credit Facility
|
$
|
|
$
|
|
||||
|
Convertible senior notes, due 2025
|
|
|
||||||
|
Convertible senior notes, due 2030
|
|
|
||||||
|
Deferred financing costs
|
(
|
)
|
(
|
)
|
||||
|
|
|
|||||||
|
Less current portion
|
|
|
||||||
|
|
$
|
|
$
|
|
||||
|
Due 2025
|
Due 2030
|
|||||||
|
Issuance date
|
|
|
||||||
|
Maturity date
|
|
|
||||||
|
Principal amount
|
$
|
|
$ |
|
||||
|
Cash coupon rate (per annum)
|
|
%
|
|
|||||
|
Conversion rate effective December 3, 2024 (per $1 principal amount)
|
|
|
||||||
|
Effective conversion price effective December 3, 2024 (per share)
|
$
|
|
$ |
|
||||
|
|
$
|
|
$ |
|
||||
|
Restricted stock units outstanding, assuming performance-based awards at maximum
|
|
|||
|
Phantom stock units outstanding
|
|
|||
|
2023 Long-Term Incentive Plan - available to grant
|
|
|||
|
Convertible senior notes, due 2025
|
|
|||
| Convertible senior notes, due 2030 |
|
|||
|
Conversion of Class B common stock
|
|
|||
|
Total
|
|
|
Years ended December 31,
|
||||||||
|
2024
|
2023 | |||||||
|
Dividends paid to stockholders
|
$ |
|
$ |
|
||||
|
Stock repurchases
|
|
|
||||||
|
Total
|
$ |
|
$ |
|
||||
|
|
Years ended December 31,
|
|||||||||||
|
|
2024
|
2023
|
2022
|
|||||||||
|
|
||||||||||||
|
Foreign exchange gain
|
$
|
|
$
|
|
$
|
|
||||||
|
Interest income
|
|
|
|
|||||||||
|
Other components of periodic pension expense
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Investment income (expense)
|
(
|
)
|
|
(
|
)
|
|||||||
|
Other
|
|
|
(
|
)
|
||||||||
|
|
$
|
|
$
|
|
$
|
(
|
)
|
|||||
|
December 31,
|
||||||||
|
|
2024
|
2023
|
||||||
|
|
||||||||
|
Sales returns and allowances
|
$
|
|
$
|
|
||||
|
Goods received, not yet invoiced
|
|
|
||||||
|
Accrued VAT taxes payable
|
|
|
||||||
|
Other
|
|
|
||||||
|
|
$
|
|
$
|
|
||||
|
Years Ended December 31,
|
||||||||||||
|
|
2024
|
2023
|
2022
|
|||||||||
|
Beginning balance
|
$
|
|
$
|
|
$
|
|
||||||
|
Sales returns and allowances
|
|
|
|
|||||||||
|
Credits issued
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Foreign currency
|
(
|
)
|
|
(
|
)
|
|||||||
|
Ending balance
|
$
|
|
$
|
|
$
|
|
||||||
|
Pension and
other post-
retirement
actuarial items
|
Currency
translation
adjustment
|
Total
|
||||||||||
|
Balance at January 1,
2022
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
||||
|
Other comprehensive income before reclassifications
|
|
(
|
)
|
$
|
|
|||||||
|
Tax effect
|
(
|
)
|
|
$
|
(
|
)
|
||||||
|
Other comprehensive income before reclassifications, net of tax
|
|
(
|
)
|
$
|
|
|||||||
|
Amounts reclassified out of AOCI
|
|
|
$
|
|
||||||||
|
Tax effect
|
(
|
)
|
|
$
|
(
|
)
|
||||||
|
Amounts reclassified out of AOCI, net of tax
|
|
|
$
|
|
||||||||
|
Net comprehensive income (loss)
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||
|
Balance at December 31,
2022
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
|||
|
Other comprehensive income before reclassifications
|
(
|
)
|
|
$
|
|
|||||||
|
Tax effect
|
|
|
$
|
|
||||||||
|
Other comprehensive income before reclassifications, net of tax
|
(
|
)
|
|
$
|
|
|||||||
|
Amounts reclassified out of AOCI
|
|
|
$
|
|
||||||||
|
Tax effect
|
(
|
)
|
|
$
|
(
|
)
|
||||||
|
Amounts reclassified out of AOCI, net of tax
|
|
|
$
|
|
||||||||
|
Net comprehensive income (loss)
|
$
|
(
|
)
|
$
|
|
$
|
|
|||||
|
Balance at December 31,
2023
|
$
|
(
|
)
|
$
|
|
$
|
|
|||||
|
Other comprehensive income before reclassifications
|
|
(
|
)
|
$
|
(
|
)
|
||||||
|
Tax effect
|
(
|
)
|
|
$
|
(
|
)
|
||||||
|
Other comprehensive income before reclassifications, net of tax
|
|
(
|
)
|
$
|
(
|
)
|
||||||
|
Amounts reclassified out of AOCI
|
|
|
$
|
|
||||||||
|
Tax effect
|
(
|
)
|
|
$
|
(
|
)
|
||||||
|
Amounts reclassified out of AOCI, net of tax
|
|
|
$
|
|
||||||||
|
Net comprehensive income (loss)
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
||||
|
Balance at December 31,
2024
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
|||
|
December 31,
|
||||||||
|
2024
|
2023
|
|||||||
|
|
||||||||
|
Included in "Other assets":
|
||||||||
|
Non-U.S. pension plans
|
$
|
|
$
|
|
||||
|
Total included in other assets
|
$
|
|
$
|
|
||||
|
Included in "Payroll and related expenses":
|
||||||||
|
U.S. pension plans
|
$
|
(
|
)
|
$
|
(
|
)
|
||
|
Non-U.S. pension plans
|
(
|
)
|
(
|
)
|
||||
|
U.S. other postretirement plans
|
(
|
)
|
(
|
)
|
||||
|
Non-U.S. other postretirement plans
|
(
|
)
|
(
|
)
|
||||
|
Total included in payroll and related expenses
|
$
|
(
|
)
|
$
|
(
|
)
|
||
|
Accrued pension and other postretirement costs:
|
||||||||
|
U.S. pension plans
|
$
|
(
|
)
|
$
|
(
|
)
|
||
|
Non-U.S. pension plans
|
(
|
)
|
(
|
)
|
||||
|
U.S. other postretirement plans
|
(
|
)
|
(
|
)
|
||||
|
Non-U.S. other postretirement plans
|
(
|
)
|
(
|
)
|
||||
|
Other retirement obligations
|
(
|
)
|
(
|
)
|
||||
|
Total accrued pension and other postretirement costs
|
$
|
(
|
)
|
$
|
(
|
)
|
||
|
Accumulated other comprehensive loss:
|
||||||||
|
U.S. pension plans
|
$
|
|
$
|
(
|
)
|
|||
|
Non-U.S. pension plans
|
|
|
||||||
|
U.S. other postretirement plans
|
(
|
)
|
(
|
)
|
||||
|
Non-U.S. other postretirement plans
|
|
|
||||||
|
Total accumulated other comprehensive loss*
|
$
|
|
$
|
|
||||
|
December 31, 2024
|
December 31, 2023
|
|||||||||||||||
|
|
U.S.
Plans
|
Non-U.S.
Plans
|
U.S.
Plans
|
Non-U.S.
Plans
|
||||||||||||
|
Change in benefit obligation:
|
||||||||||||||||
|
Benefit obligation at beginning of year
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Service cost
|
|
|
|
|
||||||||||||
|
Interest cost
|
|
|
|
|
||||||||||||
|
Plan amendments
|
|
|
|
(
|
)
|
|||||||||||
|
Actuarial (gains) losses
|
(
|
)
|
|
(
|
)
|
|
||||||||||
|
Benefits paid
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||
|
Curtailments and settlements
|
|
(
|
)
|
|
(
|
)
|
||||||||||
|
Currency translation
|
|
(
|
)
|
|
|
|||||||||||
|
Benefit obligation at end of year
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Change in plan assets:
|
||||||||||||||||
|
Fair value of plan assets at beginning of year
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Actual return on plan assets
|
|
|
|
|
||||||||||||
|
Company contributions
|
|
|
|
|
||||||||||||
|
Benefits paid
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||
|
Currency translation
|
|
(
|
)
|
|
|
|||||||||||
|
Fair value of plan assets at end of year
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Funded status at end of year
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
||||
|
December 31, 2024
|
December 31, 2023
|
|||||||||||||||
|
U.S.
Plans
|
Non-U.S.
Plans
|
U.S.
Plans
|
Non-U.S.
Plans
|
|||||||||||||
|
Other assets
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Accrued benefit liability - current
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||
|
Accrued benefit liability - non-current
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||
|
Accumulated other comprehensive loss
|
|
|
(
|
)
|
|
|||||||||||
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
||||
|
December 31, 2024
|
December 31, 2023
|
|||||||||||||||
|
U.S.
Plans
|
Non-U.S.
Plans
|
U.S.
Plans
|
Non-U.S.
Plans
|
|||||||||||||
|
Unrecognized net actuarial (gain) loss
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||||
|
Unamortized prior service cost
|
|
|
|
|
||||||||||||
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||||
|
December 31, 2024
|
December 31, 2023
|
|||||||||||||||
|
U.S.
Plans
|
Non-U.S.
Plans
|
U.S.
Plans
|
Non-U.S.
Plans
|
|||||||||||||
|
Accumulated benefit obligation, all plans
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Plans for which the accumulated benefit obligation exceeds plan assets:
|
||||||||||||||||
|
Projected benefit obligation
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Accumulated benefit obligation
|
|
|
|
|
||||||||||||
|
Fair value of plan assets
|
|
|
|
|
||||||||||||
|
Years ended December 31,
|
||||||||||||||||||||||||
|
|
2024
|
2023
|
2022
|
|||||||||||||||||||||
|
|
U.S.
Plans
|
Non-U.S.
Plans
|
U.S.
Plans
|
Non-U.S.
Plans
|
U.S.
Plans
|
Non-U.S.
Plans
|
||||||||||||||||||
|
Service cost
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||
|
Interest cost
|
|
|
|
|
|
|
||||||||||||||||||
|
Expected return on plan assets
|
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
|||||||||||||||
|
Amortization of actuarial (gains) losses
|
(
|
)
|
|
|
|
|
|
|||||||||||||||||
|
Amortization of prior service cost
|
|
|
|
|
|
|
||||||||||||||||||
|
Curtailment and settlement losses
|
|
|
|
|
|
|
||||||||||||||||||
|
Net periodic pension cost
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||
|
2024
|
2023
|
|||||||||||||||
|
U.S.
Plans
|
Non-U.S.
Plans
|
U.S.
Plans
|
Non-U.S.
Plans
|
|||||||||||||
|
Discount rate
|
|
%
|
|
%
|
|
%
|
|
%
|
||||||||
|
Rate of compensation increase
|
|
%
|
|
%
|
|
%
|
|
%
|
||||||||
|
Years ended December 31,
|
||||||||||||||||
|
|
2024
|
2023
|
||||||||||||||
|
|
U.S.
Plans
|
Non-U.S.
Plans
|
U.S.
Plans
|
Non-U.S.
Plans
|
||||||||||||
|
Discount rate
|
|
%
|
|
%
|
|
%
|
|
%
|
||||||||
|
Rate of compensation increase
|
|
%
|
|
%
|
|
%
|
|
%
|
||||||||
|
Expected return on plan assets
|
|
%
|
|
%
|
|
%
|
|
%
|
||||||||
|
U.S.
Plans
|
Non-U.S.
Plans
|
|||||||
|
2025
|
$
|
|
$
|
|
||||
|
2026
|
|
|
||||||
|
2027
|
|
|
||||||
|
2028
|
|
|
||||||
|
2029
|
|
|
||||||
|
2030-2035
|
|
|
||||||
|
December 31, 2024
|
December 31, 2023
|
|||||||||||||||
|
U.S.
Plans
|
Non-U.S.
Plans
|
U.S.
Plans
|
Non-U.S.
Plans
|
|||||||||||||
|
Change in benefit obligation:
|
||||||||||||||||
|
Benefit obligation at beginning of year
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Service cost
|
|
|
|
|
||||||||||||
|
Interest cost
|
|
|
|
|
||||||||||||
|
Actuarial (gains) losses
|
(
|
)
|
(
|
)
|
|
|
||||||||||
|
Benefits paid
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||
|
Currency translation
|
|
(
|
)
|
|
|
|||||||||||
|
Benefit obligation at end of year
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Fair value of plan assets at end of year
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Funded status at end of year
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
||||
|
December 31, 2024
|
December 31, 2023
|
|||||||||||||||
|
U.S.
Plans
|
Non-U.S.
Plans
|
U.S.
Plans
|
Non-U.S.
Plans
|
|||||||||||||
|
Accrued benefit liability - current
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
||||
|
Accrued benefit liability - non-current
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||
|
Accumulated other comprehensive (income) loss
|
(
|
)
|
|
(
|
)
|
|
||||||||||
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
||||
|
December 31, 2024
|
December 31, 2023
|
|||||||||||||||
|
U.S.
Plans
|
Non-U.S.
Plans
|
U.S.
Plans
|
Non-U.S.
Plans
|
|||||||||||||
|
Unrecognized net actuarial loss (gain)
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
$
|
|
||||||
|
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
$
|
|
||||||
|
Years ended December 31,
|
||||||||||||||||||||||||
|
|
2024
|
2023
|
2022
|
|||||||||||||||||||||
|
U.S.
Plans
|
Non-U.S.
Plans
|
U.S.
Plans
|
Non-U.S.
Plans
|
U.S.
Plans
|
Non-U.S.
Plans
|
|||||||||||||||||||
|
Service cost
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||
|
Interest cost
|
|
|
|
|
|
|
||||||||||||||||||
|
Amortization of actuarial (gains) losses
|
(
|
)
|
|
(
|
)
|
|
|
|
||||||||||||||||
|
Curtailment and settlement losses
|
|
|
|
|
|
|
||||||||||||||||||
|
Net periodic benefit cost (benefit)
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
|
$
|
|
||||||||||
|
2024
|
2023
|
|||||||||||||||
|
|
U.S.
Plans
|
Non-U.S.
Plans
|
U.S.
Plans
|
Non-U.S.
Plans
|
||||||||||||
|
Discount rate
|
|
%
|
|
%
|
|
%
|
|
%
|
||||||||
|
Rate of compensation increase
|
|
%
|
|
%
|
|
%
|
|
%
|
||||||||
|
|
Years ended December 31,
|
|||||||||||||||
|
|
2024
|
2023
|
||||||||||||||
|
|
U.S.
Plans
|
Non-U.S.
Plans
|
U.S.
Plans
|
Non-U.S.
Plans
|
||||||||||||
|
Discount rate
|
|
%
|
|
%
|
|
%
|
|
%
|
||||||||
|
Rate of compensation increase
|
|
%
|
|
%
|
|
%
|
|
%
|
||||||||
|
U.S.
Plans
|
Non-U.S.
Plans
|
|||||||
|
2025
|
$
|
|
$
|
|
||||
|
2026
|
|
|
||||||
|
2027
|
|
|
||||||
|
2028
|
|
|
||||||
|
2029
|
|
|
||||||
|
2030-2035
|
|
|
||||||
|
Years ended December 31,
|
||||||||||||
|
|
2024
|
2023
|
2022
|
|||||||||
|
|
||||||||||||
|
Restricted stock units
|
$
|
|
$
|
|
$
|
|
||||||
|
Phantom stock units
|
|
|
|
|||||||||
|
Total
|
$
|
|
$
|
|
$
|
|
||||||
|
Unrecognized
Compensation
Cost
|
Weighted
Average
Remaining
Amortization
Periods
|
|||||||
|
|
||||||||
|
Restricted stock units
|
$
|
|
|
|||||
|
Phantom stock units
|
|
-
|
||||||
|
Total
|
$
|
|
||||||
|
Years ended December 31,
|
||||||||||||||||||||||||
|
|
2024
|
2023
|
2022
|
|||||||||||||||||||||
|
|
Number of
RSUs
|
Weighted
Average
Grant-date
Fair Value
|
Number of
RSUs
|
Weighted
Average
Grant-date
Fair Value
|
Number of
RSUs
|
Weighted
Average
Grant-date
Fair Value
|
||||||||||||||||||
|
|
||||||||||||||||||||||||
|
Outstanding:
|
||||||||||||||||||||||||
|
Beginning of year
|
|
$
|
|
|
$
|
|
|
$
|
|
|||||||||||||||
|
Granted*
|
|
|
|
|
|
|
||||||||||||||||||
|
Vested**
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
|
|||||||||||||||
|
Cancelled or forfeited
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
|
|||||||||||||||
|
End of year
|
|
$
|
|
|
$
|
|
|
$
|
|
|||||||||||||||
|
|
||||||||||||||||||||||||
|
Expected to vest
|
|
|
|
|||||||||||||||||||||
|
Vesting Date
|
Expected to
Vest
|
Not Expected
to Vest
|
Total
|
|||||||||
|
January 1, 2025***
|
|
|
|
|||||||||
|
January 1, 2026
|
|
|
|
|||||||||
|
January 1, 2027
|
|
|
|
|||||||||
|
March 1, 2029
|
|
|
|
|||||||||
|
Years ended December 31,
|
||||||||||||||||||||||||
|
|
2024
|
2023
|
2022
|
|||||||||||||||||||||
|
Number of
Phantom
Stock Units
|
Grant-date
Fair Value per
Unit
|
Number of
Phantom
Stock Units
|
Grant-date
Fair Value per
Unit
|
Number of
Phantom
Stock Units
|
Grant-date
Fair Value per
Unit
|
|||||||||||||||||||
|
Outstanding:
|
||||||||||||||||||||||||
|
Beginning of year
|
|
|
|
|||||||||||||||||||||
|
Granted
|
|
$
|
|
|
$
|
|
|
$ |
|
|||||||||||||||
|
Dividend equivalents issued
|
|
|
|
|||||||||||||||||||||
|
Redeemed for common stock*
|
|
(
|
) |
|
||||||||||||||||||||
|
End of year
|
|
|
|
|||||||||||||||||||||
|
JPMorgan*
|
|
%
|
||
|
MUFG Bank Ltd.*
|
|
% | ||
|
Bank Leumi*
|
|
% | ||
|
HSBC*
|
|
% |
|
The Republic of China (Taiwan)
|
|
% | ||
|
Singapore
|
|
% | ||
|
People's Republic of China
|
|
%
|
||
|
Israel
|
|
% | ||
|
United States
|
|
% | ||
|
Germany
|
|
% | ||
|
Other Asia
|
|
%
|
||
|
Other Europe
|
|
%
|
||
|
Other
|
|
%
|
|
●
|
Metal oxide semiconductor field effect transistors ("MOSFETs") function as solid state switches to control power.
|
|
|
●
|
|
Diodes route, regulate, and block radio frequency, analog, and power signals; protect systems from surges or electrostatic discharge damage; or provide
electromagnetic interference filtering.
|
|
●
|
Optoelectronic components emit light, detect light, or do both.
|
|
|
●
|
|
Resistors are basic components used in all forms of electronic circuitry to adjust and regulate levels of voltage and current.
|
|
●
|
Inductors use an internal magnetic field to change alternating current phase and resist alternating current.
|
|
|
●
|
Capacitors store energy and discharge it when needed.
|
|
MOSFETs
|
Diodes
|
Optoelectronic
Components
|
Resistors
|
Inductors
|
Capacitors
|
Corporate /
Other
|
Total
|
|||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||
|
Year ended December 31, 2024:
|
|
|||||||||||||||||||||||||||||||
|
Net revenues
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||
|
Cost of products sold (excluding depreciation)
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||
|
Depreciation expense in cost of products sold
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
|
Total cost of products sold
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
|
Gross profit
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
|
Segment operating expenses
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||
|
Segment operating income
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||
|
Total depreciation expense
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||
|
Capital expenditures
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||
|
Total assets as of December 31,
2024
:
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||
|
|
||||||||||||||||||||||||||||||||
|
Year ended December 31, 2023:
|
||||||||||||||||||||||||||||||||
|
Net revenues
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||
|
Cost of products sold (excluding depreciation)
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||
|
Depreciation expense in cost of products sold
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
|
Total cost of products sold
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
|
Gross profit
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
|
Segment operating expenses
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||
|
Segment operating income
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||
|
Total depreciation expense
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||
|
Capital expenditures
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||
|
Total assets as of December 31,
2023
:
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||
|
|
||||||||||||||||||||||||||||||||
|
Year ended December 31, 2022:
|
||||||||||||||||||||||||||||||||
|
Net revenues
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||
|
Cost of products sold (excluding depreciation)
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||
|
Depreciation expense in cost of products sold
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
|
Total cost of products sold
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
|
Gross profit
|
|
|
|
|
|
|
(
|
) |
|
|||||||||||||||||||||||
|
Segment operating expenses
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||
|
Segment operating income
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
) | $ |
|
|||||||||||||||
|
Total depreciation expense
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||
|
Capital expenditures
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||
|
Total assets as of December 31,
2022
:
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||
|
Years ended December 31,
|
||||||||||||
|
|
2024
|
2023
|
2022
|
|||||||||
|
Reconciliation:
|
||||||||||||
|
Segment Operating Income
|
$
|
|
$
|
|
$
|
|
||||||
|
Restructuring and Severance Costs
|
(
|
) |
|
|
||||||||
|
Impairment of Goodwill
|
(
|
) |
|
|
||||||||
|
Impact of COVID-19 Pandemic on Selling, General, and Administrative Expenses
|
|
|
(
|
) | ||||||||
|
Unallocated Selling, General, and Administrative Expenses
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Consolidated Operating Income (Loss)
|
$
|
|
$
|
|
$
|
|
||||||
|
Unallocated Other Income (Expense)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Consolidated Income (Loss) Before Taxes
|
$
|
(
|
)
|
$
|
|
$
|
|
|||||
|
Years Ended December 31,
|
||||||||||||
|
|
2024
|
2023
|
2022
|
|||||||||
|
Distributors
|
$
|
|
$
|
|
$
|
|
||||||
|
OEMs
|
|
|
|
|||||||||
|
EMS companies
|
|
|
|
|||||||||
|
$
|
|
$
|
|
$
|
|
|||||||
|
|
Years Ended December 31,
|
|||||||||||
|
|
2024
|
2023
|
2022
|
|||||||||
|
Asia
|
$
|
|
$
|
|
$
|
|
||||||
|
Europe
|
|
|
|
|||||||||
|
Americas
|
|
|
|
|||||||||
|
$
|
|
$
|
|
$
|
|
|||||||
|
Years Ended December 31,
|
||||||||||||
|
|
2024
|
2023
|
2022
|
|||||||||
|
Industrial
|
$
|
|
$
|
|
$
|
|
||||||
|
Automotive
|
|
|
|
|||||||||
| Military and Aerospace |
|
|
|
|||||||||
|
Medical
|
|
|
|
|||||||||
|
Other*
|
|
|
|
|||||||||
|
$
|
|
$
|
|
$
|
|
|||||||
|
|
Years ended December 31,
|
|||||||||||
|
|
2024
|
2023
|
2022
|
|||||||||
|
|
||||||||||||
|
United States
|
$
|
|
$
|
|
$
|
|
||||||
|
Germany
|
|
|
|
|||||||||
|
Other Europe
|
|
|
|
|||||||||
|
Israel
|
|
|
|
|||||||||
|
Asia
|
|
|
|
|||||||||
|
$
|
|
$
|
|
$
|
|
|||||||
|
December 31,
|
||||||||
|
|
2024
|
2023
|
||||||
|
|
||||||||
|
United States
|
$
|
|
$
|
|
||||
|
Germany
|
|
|
||||||
|
United Kingdom
|
|
|
|
|||||
|
Other Europe
|
|
|
||||||
|
Israel
|
|
|
||||||
|
People's Republic of China
|
|
|
||||||
|
Republic of China (Taiwan)
|
|
|
||||||
|
Other Asia
|
|
|
||||||
|
Other
|
|
|
||||||
|
|
$
|
|
$
|
|
||||
|
Years ended December 31,
|
||||||||||||
|
2024
|
2023
|
2022
|
||||||||||
|
Numerator:
|
||||||||||||
|
Net earnings (loss) attributable to Vishay stockholders
|
$
|
(
|
)
|
$
|
|
$
|
|
|||||
|
Denominator:
|
||||||||||||
|
Denominator for basic earnings (loss) per share:
|
||||||||||||
|
Weighted average shares
|
|
|
|
|||||||||
|
Outstanding phantom stock units
|
|
|
|
|||||||||
|
Adjusted weighted average shares - basic
|
|
|
|
|||||||||
|
Effect of dilutive securities:
|
||||||||||||
|
Restricted stock units
|
|
|
|
|||||||||
|
Dilutive potential common shares
|
|
|
|
|||||||||
|
Denominator for diluted earnings (loss) per share:
|
||||||||||||
|
Adjusted weighted average shares - diluted
|
|
|
|
|||||||||
|
Basic earnings (loss) per share attributable to Vishay stockholders
|
$
|
(
|
)
|
$
|
|
$
|
|
|||||
|
Diluted earnings (loss) per share attributable to Vishay stockholders
|
$
|
(
|
)
|
$
|
|
$
|
|
|||||
|
Years ended December 31,
|
||||||||||||
|
|
2024
|
2023
|
2022
|
|||||||||
|
Restricted stock units
|
|
|
|
|||||||||
|
Years ended December 31,
|
||||||||||||
|
|
2024
|
2023
|
2022
|
|||||||||
|
|
||||||||||||
|
Accounts receivable
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
||||
|
Inventories
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Prepaid expenses and other current assets
|
|
(
|
)
|
(
|
)
|
|||||||
|
Accounts payable
|
|
|
(
|
)
|
||||||||
|
Other current liabilities
|
(
|
)
|
(
|
)
|
|
|||||||
|
Net change in operating assets and liabilities
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
|||
|
Total Fair Value
|
Level 1
|
Level 2
|
Level 3
|
|||||||||||||
|
December 31,
2024
|
||||||||||||||||
|
Assets:
|
||||||||||||||||
|
Assets held in rabbi trusts
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Available for sale securities
|
$
|
|
|
|
|
|||||||||||
|
Non - U.S. Defined Benefit Pension Plan Assets:
|
||||||||||||||||
|
Equity securities
|
$
|
|
|
|
|
|||||||||||
|
Fixed income securities
|
$
|
|
|
|
|
|||||||||||
|
Cash
|
$
|
|
|
|
|
|||||||||||
|
$
|
|
$
|
|
$
|
|
$
|
|
|||||||||
|
Liability:
|
||||||||||||||||
|
Acquisitions contingent consideration
|
$ |
|
|
|
|
|||||||||||
|
December 31,
2023
|
||||||||||||||||
|
Assets:
|
||||||||||||||||
|
Assets held in rabbi trusts
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Available for sale securities
|
$
|
|
|
|
|
|||||||||||
|
Non - U.S. Defined Benefit Pension Plan Assets:
|
||||||||||||||||
|
Equity securities
|
$
|
|
|
|
$ |
|
||||||||||
|
Fixed income securities
|
$
|
|
|
|
|
|||||||||||
|
Cash
|
$
|
|
|
|
|
|||||||||||
|
$
|
|
$
|
|
$
|
|
$
|
|
|||||||||
| Liability: | ||||||||||||||||
|
MaxPower acquisition contingent consideration
|
$
|
|
|
|
|
|||||||||||
| MOSFETs |
Optoelectronic
Components
|
Resistors
|
Inductors
|
Capacitors
|
Total
|
|||||||||||||||||||
|
Balance at December 31, 2022
|
$ |
|
$
|
|
$
|
|
$
|
|
$ |
|
$
|
|
||||||||||||
|
Centerline acquisition
|
|
|
|
|
|
|
||||||||||||||||||
|
Purchase price allocation adjustment
|
(
|
) |
|
|
|
|
(
|
) | ||||||||||||||||
|
Exchange rate effects
|
|
|
|
|
|
|
||||||||||||||||||
|
Balance at December 31, 2023
|
$ |
|
$
|
|
$
|
|
$
|
|
$ |
|
$
|
|
||||||||||||
|
Newport acquisition
|
|
|
|
|
|
|
||||||||||||||||||
|
Ametherm acquisition
|
|
|
|
|
|
|
||||||||||||||||||
|
Birkelbach acquisition
|
|
|
|
|
|
|
||||||||||||||||||
|
Impairment of goodwill
|
(
|
) |
|
|
|
|
(
|
) | ||||||||||||||||
|
Exchange rate effects
|
|
|
(
|
)
|
|
|
(
|
)
|
||||||||||||||||
|
Balance at December 31, 2024
|
$ |
|
$
|
|
$
|
|
$
|
|
$ |
|
$
|
|
||||||||||||
|
December 31,
2024
|
December 31,
2023
|
|||||||
|
Intangible assets subject to amortization:
|
||||||||
|
Patents and acquired technology
|
$
|
|
$
|
|
||||
|
Capitalized software
|
|
|
||||||
|
Customer relationships
|
|
|
||||||
|
Tradenames
|
|
|
||||||
|
Other
|
|
|
||||||
|
|
|
|||||||
|
Accumulated amortization:
|
||||||||
|
Patents and acquired technology
|
(
|
)
|
(
|
)
|
||||
|
Capitalized software
|
(
|
)
|
(
|
)
|
||||
|
Customer relationships
|
(
|
)
|
(
|
)
|
||||
|
Tradenames
|
(
|
)
|
(
|
)
|
||||
|
Other
|
|
(
|
)
|
|||||
|
(
|
)
|
(
|
)
|
|||||
|
Net intangible assets subject to amortization
|
$
|
|
$
|
|
||||
|
2025
|
$
|
|
||
|
2026
|
|
|||
|
2027
|
|
|||
|
2028
|
|
|||
|
2029
|
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|